Emerging Infectious Diseases

Papers
(The H4-Index of Emerging Infectious Diseases is 88. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients1267
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 21144
Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020771
COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020662
US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2495
Serial Interval of COVID-19 among Publicly Reported Confirmed Cases476
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States475
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Social Distancing Measures435
Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020432
Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19421
Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020396
Coronavirus Disease Outbreak in Call Center, South Korea390
Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic387
Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020380
Public Mental Health Crisis during COVID-19 Pandemic, China376
Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China364
Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020362
Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease316
Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States305
Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India302
Community Responses during Early Phase of COVID-19 Epidemic, Hong Kong298
Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010–2018295
Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China290
Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols274
Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions251
Rhabdomyolysis as Potential Late Complication Associated with COVID-19247
Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China245
Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality232
Decreased Influenza Incidence under COVID-19 Control Measures, Singapore229
Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China228
SARS-CoV-2 Transmission between Mink (Neovison vison) and Humans, Denmark222
Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April–July 2020219
Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2213
Identifying and Interrupting Superspreading Events—Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2211
Cluster of Coronavirus Disease Associated with Fitness Dance Classes, South Korea200
Imported Monkeypox, Singapore197
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease194
Clusters of Coronavirus Disease in Communities, Japan, January–April 2020181
COVID-19–Associated Pulmonary Aspergillosis, March–August 2020174
Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States171
Effectiveness of N95 Respirator Decontamination and Reuse against SARS-CoV-2 Virus167
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil167
Prolonged Infectivity of SARS-CoV-2 in Fomites162
Monitoring SARS-CoV-2 Circulation and Diversity through Community Wastewater Sequencing, the Netherlands and Belgium160
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Personal Protective and Environmental Measures158
Transmission of SARS-CoV 2 During Long-Haul Flight157
Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul, South Korea153
Case-Control Study of Use of Personal Protective Measures and Risk for SARS-CoV 2 Infection, Thailand151
Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017–2020149
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France148
Estimating Risk for Death from Coronavirus Disease, China, January–February 2020146
Imported Monkeypox from International Traveler, Maryland, USA, 2021145
Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China145
Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations145
Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan145
SARS-CoV-2 in Quarantined Domestic Cats from COVID-19 Households or Close Contacts, Hong Kong, China145
Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids142
Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021141
SARS-CoV-2 Natural Transmission from Human to Cat, Belgium, March 2020141
Experimental Infection of Cattle with SARS-CoV-2139
Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection135
Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum135
Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020134
Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan134
Aspergillosis Complicating Severe Coronavirus Disease129
Policy Decisions and Use of Information Technology to Fight Coronavirus Disease, Taiwan118
Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2116
Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan115
Viral Interference between Respiratory Viruses114
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020114
Detection and Characterization of Bat Sarbecovirus Phylogenetically Related to SARS-CoV-2, Japan114
Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2111
Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient109
Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents108
Comparison of Lyme Disease in the United States and Europe106
Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan102
Suspected Cat-to-Human Transmission of SARS-CoV-2, Thailand, July–September 2021101
Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection100
Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2100
Epidemiologic Evidence for Airborne Transmission of SARS-CoV-2 during Church Singing, Australia, 202099
Coronavirus Disease among Workers in Food Processing, Food Manufacturing, and Agriculture Workplaces97
Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection95
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity94
Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20–May 21, 202092
Epidemiology of Coronavirus Disease in Gansu Province, China, 202091
Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States89
Asymptomatic Transmission of SARS-CoV-2 on Evacuation Flight89
Detection of Severe Acute Respiratory Syndrome Coronavirus 2 RNA on Surfaces in Quarantine Rooms88
Intercontinental Movement of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4 Virus to the United States, 202188
0.097100973129272